The tissue expression of SMYD3 was significantly positively correlated with the expression of transforming growth factor β1 (TGF-β1) in GC, whereas the prognosis of GC patients with high SMYD3 and TGF-β1 expression was poor (Liu H. et al., 2015). The gene discussed is SMYD3; the disease is gastric cancer.